Endodontik Tedavilerde Ağrının Mekanizması ve Analjeziklerin Rolü
Özet
Ağrı, Uluslararası Ağrı Araştırmaları Birliği (IASP) tarafından, “gerçek veya potansiyel doku hasarıyla ilişkili hoş olmayan duyusal ve duygusal bir deneyim” olarak tanımlanmaktadır. Diş hekimine başvuruların en yaygın nedenlerinden biri ağrıdır. Diş hekimi öncelikli olarak ağrıya neden olan patolojinin teşhisi yapılmalı, ardından uygun tedavi uygulanmalı ve ilaç kullanımı gerekli durumlarla sınırlandırılmalıdır.
Diş ve çevre dokularla ilişkili ağrılar genellikle inflamasyon kaynaklıdır ve enfeksiyon, travma ya da cerrahi girişimler sonrası gelişebilir. Endodontik ağrı yönetimi, etkili bir endodontik tedavi ile uygun analjezik kullanımının kombinasyonunu içerir. Bu amaçla non-narkotik analjezikler (parasetamol, NSAİİ) ve narkotik analjezikler (opioidler) kullanılmaktadır. NSAİİ’ler, COX-1 ve COX-2 enzimlerini inhibe ederek prostaglandin sentezini azaltır ve inflamasyona bağlı ağrıyı etkili bir şekilde kontrol altına alır. İbuprofen, flurbiprofen, deksketoprofen, naproksen sodyum, etodolak ve diklofenak bu gruptadır ve en sık tercih edilen ilaçlardan biri ibuprofendir. Parasetamol ise güçlü analjezik ve antipiretik özelliklere sahip olup antiinflamatuar etkisi sınırlıdır.
Opioidler, güçlü analjezik özellikleri nedeniyle bazı diş hekimliği uygulamalarında kullanılmakla birlikte, bağımlılık riski nedeniyle dikkatli reçetelendirilmelidir. Diş hekimliğinde ağrı yönetimi, farmakolojik ve klinik yaklaşımların birlikte uygulanmasını gerektirir.
Pain is defined by the International Association for the Study of Pain (IASP) as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage”. One of the most common reasons for visiting the dentist is pain. The dentist should first diagnose the pathology causing the pain, then apply the appropriate treatment, and limit medication use to necessary cases.
Pain related to the teeth and surrounding tissues is usually caused by inflammation and may develop due to infection, trauma, or surgical procedures. Endodontic pain management involves a combination of effective endodontic treatment and appropriate use of analgesics. For this purpose, non-narcotic analgesics (paracetamol, NSAIDs) and narcotic analgesics (opioids) are used. NSAIDs inhibit COX-1 and COX-2 enzymes, reducing prostaglandin synthesis and effectively controlling inflammation-related pain. Ibuprofen, flurbiprofen, dexketoprofen, naproxen sodium, etodolac, and diclofenac belong to this group, with ibuprofen being one of the most commonly preferred drugs. Paracetamol has strong analgesic and antipyretic properties, but its anti-inflammatory effect is limited.
Opioids are used in some dental procedures due to their strong analgesic properties; however, they should be prescribed with caution due to the risk of addiction. Pain management in dentistry requires the combined application of pharmacological and clinical approaches.
Referanslar
Görmez Ö, Çelebi E. Ağrı Mekanizmaları ve Fizyolojisi. Turkiye Klinikleri Oral and Maxillofacial Radiology-Special Topics. 2021;7(2):9-15.
Aydın On. Ağrı ve ağrı mekanizmalarına güncel bakış. ADÜ Tıp Fakültesi Dergisi 2002; 3(2) : 37 - 48.
Hargreaves K, Abbott P. Drugs for pain management in dentistry. Australian Dental Journal. 2005;50:S14-S22.
Hargreaves K. Endodontic pharmacology. Pathways of pulp. 2001.
Kaya BU, Çiçek E, Aşçı H. Endodontide ağrı ve analjezik kullanımı. SDU Journal of Health Science Institute/SDÜ Saglik Bilimleri Enstitüsü Dergisi. 2013;4(1).
Şimşek N, Bulut et, Akinci L. Endodontik Ağrıya Yönelik Sistemik İlaç Kullanımı. Turkiye Klinikleri Endodontics-Special Topics. 2018;4(2):68-76.
Bunczak-Reeh MA, Hargreaves KM. Effect of inflammation on the delivery of drugs to dental pulp. Journal of Endodontics. 1998;24(12):822-5.
Hargreaves KM, Keiser K. New Advances in the Management of Endodontic Pa in Emergencies. Journal of the California Dental Association. 2004;32(6):469-73.
Seymour RA, Meechan JG, Yates MS, Walton J. Pharmacology and Dental Therapeutics. Oxford Üniversitesi Yayınları.1999.
DiLorenzo AN, Schell RM. Morgan & Mikhail’s clinical anesthesiology. Anesthesia & Analgesia. 2014;119(2):495-6.
Öztürk Z. Endodontiyle İlişkili Temel Ağrı Biyolojisi ve Ağrı Nedenleri. Turkiye Klinikleri Endodontics-Special Topics. 2018;4(2):1-7.
Trowbridge HO. Review of dental pain—histology and physiology. Journal of Endodontics. 1986;12(10):445-52.
Byers M, Narhi M. Dental injury models: experimental tools for understanding neuroinflammatory interactions and polymodal nociceptor functions. Critical Reviews in Oral Biology & Medicine. 1999;10(1):4-39.
Hargreaves KM, Cohen S. Cohen's Pathways of the Pulp: Elsevier; 2010.
Yegül İ. Ağrı ve tedavisi: Yayl. y.; İzmir, Yapım Matbaacılık. 1993.
Nörofizyolojisi YAAA. Hasta Kontrollü Analjezi (PCA). İstanbul, MER Matbaacılık& Yayıncılık. 1997.
RA M. Peripheral mechanisms of cutaneous nociception. Wall and Melzack's Textbook of Pain. 2006.
Keiser K, Byrne BE. Endodontic pharmacology. Cohen's Pathways of the Pulp: Elsevier; 2011. p. 671-90.
Heyeraas K, Kvinnsland I. Tissue pressure and blood flow in pulpal inflammation. Proceedings of the Finnish Dental Society Suomen Hammaslaakariseuran Toimituksia. 1992;88:393-401.
Kim S. Neurovascular interactions in the dental pulp in health and inflammation. Journal of Endodontics. 1990;16(2):48-53.
Hildebrand C, Fried K, Tuisku F, Johansson C. Teeth and tooth nerves. Progress in Neurobiology. 1995;45(3):165-222.
Johnsen D, Johns S. Quantitation of nerve fibres in the primary and permanent canine and incisor teeth in man. Archives of Oral Biology. 1978;23(9):825-9.
Reader A, Foreman DW. An ultrastructural quantitative investigation of human intradental innervation. Journal of Endodontics. 1981;7(11):493-9.
Byers MR. Dental sensory receptors. International Review of Neurobiology. 1984;25:39-94.
Närhi M. The characteristics of intradental sensory units and their responses to stimulation. Journal of Dental Research. 1985;64(4):564-71.
Jyväsjärvi E, Kniffki K. Cold stimulation of teeth: a comparison between the responses of cat intradental A delta and C fibres and human sensation. The Journal of Physiology. 1987;391(1):193-207.
Närhi M, Jyväsjärvi E, Virtanen A, Huopaniemi T, Ngassapa D, Hirvonen T. Role of intradental A-and C-type nerve fibres in dental pain mechanisms. Proc Finn Dent Soc. 1992;88(Suppl 1):507-16.
Narhi M, Kontturinarhi V, editors. Sensitivity and surface condition of dentin-A SEM-replica study. Journal of Dental Research; 1994: Amer Assoc Dental Research 1619 Duke St, Alexandria, Va 22314.
Berman LH. Dentinal sensation and hypersensitivity: a review of mechanisms and treatment alternatives. Journal of Periodontology. 1985;56(4):216-22.
Jyväsjärvi E, Kniffki K. Afferent C fibre innervation of cat tooth pulp: confirmation by electrophysiological methods. The Journal of Physiology. 1989;411(1):663-75.
Holland G, Robinson P. The number and size of axons at the apex of the cat's canine tooth. The Anatomical Record. 1983;205(2):215-22.
Beasley W, Holland G. A quantitative analysis of the innervation of the pulp of the cat's canine tooth. Journal of Comparative Neurology. 1978;178(3):487-94.
Närhi M, Yamamoto H, Ngassapa D. Function of intradental nociceptors in normal and inflamed teeth. Dentin/Pulp Complex Tokyo: Quintessence. 1996:136-40.
Haug S, Heyeraas K. Effects of sympathectomy on experimentally induced pulpal inflammation and periapical lesions in rats. Neuroscience. 2003;120(3):827-36.
Kimberly C, Byers M. Inflammation of rat molar pulp and periodontium causes increased calcitonin gene‐related peptide and axonal sprouting. The Anatomical Record. 1988;222(3):289-300.
Taylor P, Byers M, Redd P. Sprouting of CGRP nerve fibers in response to dentin injury in rat molars. Brain Research. 1988;461(2):371-6.
Pigg M, Nixdorf DR, Law AS, Renton T, Sharav Y, Baad-Hansen L, et al. New international classification of orofacial pain: what is in it for endodontists? Journal of Endodontics. 2021;47(3):345-57.
Gençoğlu N. Dental Ağrı. Turkiye Klinikleri Endodontics-Special Topics. 2023;9(1):1-8.
Seltzer S. Biologic considerations in endodontic procedures. Lea and Febiger: Endodontology, 2th Edition Philadelphia, USA. 1988.
Ertekin C. Ağrının nöroanatomisi ve nörofizyolojisi. Ağrı ve Tedavisi. 1993:1-18.
Melzack R. The short-form McGill pain questionnaire. Pain. 1987;30(2):191-7.
Torabinejad M, Walton RE. Managing Endodontic Emergencis. The Journal of the American Dental Association. 1991;122(5):99-103.
Weine FS. Endodontic therapy. Mosby Yayınevi . 1982.
Walton RE, Torabinejad M. Diagnosis and treatment planning. Principles and Practice of Endodontics 3rd ed Philadelphia: Saunders. 2002:49-70.
Cohen JS, Reader A, Fertel R, Beck FM, Meyers WJ. A radioimmunoassay determination of the concentrations of prostaglandins E2 and F2α in painful and asymptomatic human dental pulps. Journal of Endodontics. 1985;11(8):330-5.
Seltzer S. Pain in endodontics. Journal of Endodontics. 2004;30(7):501-3.
Torabinejad M, Walton RE. Endodontics: principles and practice: Elsevier Health Sciences; 2009.
Hargreaves KM, Reader A, Nusstein J, Marshall J, Gibbs J. Pharmacologic management of endodontic pain. Ingle’s Endodontics. 2008;6:713-36.
Dahlen G, Bergenholtz G. Endotoxic activity in teeth with necrotic pulps. Journal of Dental Research. 1980;59(6):1033-40.
Sundqvist GK, Eckerbom M, Larsson A, Sjögren U. Capacity of anaerobic bacteria from necrotic dental pulps to induce purulent infections. Infection and Immunity. 1979;25(2):685-93.
Weiss C. The pathogenicity of Bacteroides melaninogenicus and its importance in surgical infections. Surgery. 1943;13:683-91.
Mergenhagen SE, Hampp EG, Scherp HW. Preparation and biological activities of endotoxins from oral bacteria. The Journal of Infectious Diseases. 1961:304-10.
Parnas I, Reinhold R, Fine J. Synaptic transmission in the crayfish: increased release of transmitter substance by bacterial endotoxin. Science. 1971;171(3976):1153-5.
Hook WA, Snyderman R, Mergenhagen SE. Histamine-releasing factor generated by the interaction of endotoxin with hamster serum. Infection and Immunity. 1970;2(4):462-7.
Mergenhagen S, Rosenstreich D, Wilton M, Wahl S, Wahl L. Interaction of endotoxin with lymphocytes and macrophages. The role of immunological factors in infectious, allergic, and autoimmune processes: Raven Press, New York; 1976. p. 17-27.
Pitts DL, Williams BL, Morton Jr TH. Investigation of the role of endotoxin in periapical inflammation. Journal of Endodontics. 1982;8(1):10-8.
Greengard P. Possible role for cyclic nucleotides and phosphorylated membrane proteins in postsynaptic actions of neurotransmitters. Nature. 1976;260(5547):101-8.
Sproles AC, Schilder H, Schaffer LD. Cyclic AMP and cyclic GMP concentrations in normal and pulpitic human dental pulps. Journal of Dental Research. 1979;58(12):2369-.
Bolanos OR, Seltzer S. Cyclic AMP and cyclic GMP quantitation in pulp and periapical lesions and their correlation with pain. Journal of Endodontics. 1981;7(6):268-71.
Fouad AF, Huang G. Inflammation and immunological responses. Ingle J, Bakland LK, Baumgartner JC Ingle’s Endodontics Hamilton 6th ed BC Decker Inc. 2008:343-75.
Svetcov SD, DeAngelo JE, McNamara T, Nevins AJ. Serum immunoglobulin levels and bacterial flora in subjects with acute oro-facial swellings. Journal of Endodontics. 1983;9(6):233-5.
Kettering JD, Torabinejad M. Concentrations of immune complexes, IgG, IgM, IgE, and C3 in patients with acute apical abscesses. Journal of Endodontics. 1984;10(9):417-21.
Cymerman JJ, Cymerman DH, Walters J, Nevins AJ. Human T lymphocyte subpopulations in chronic periapical lesions. Journal of Endodontics. 1984;10(1):9-11.
Scott DS, Hirschman R. Psychological aspects of dental anxiety in adults. The journal of the American dental association. 1982;104(1):27-31.
Berggren U, Meynert G. Dental fear and avoidance: causes, symptoms, and consequences. Journal of the American Dental Association (1939). 1984;109(2):247-51.
Rankin JA, Harris MB. Dental anxiety: the patient’s point of view. The Journal of the American Dental Association. 1984;109(1):43-7.
Goodis H, Poon A, Hargreaves K. Tissue pH and temperature regulate pulpal nociceptors. Journal of Dental Research. 2006;85(11):1046-9.
Johnsen D, Harshbarger J, Rymer H. Quantitative assessment of neural development in human premolars. The anatomical record. 1983;205(4):421-9.
Lane N. Pain management in osteoarthritis: the role of COX-2 inhibitors. The Journal of Rheumatology Supplement. 1997;49:20-4.
Dionne R. COX-2 inhibitors: better than ibuprofen for dental pain? Compendium of Continuing Education in Dentistry (Jamesburg, NJ: 1995). 1999;20(6):518-24.
Dionne R, Khan A, Gordon S. Analgesia and COX-2 inhibition. Clinical and Experimental Rheumatology. 2001;19(6 Suppl 25):S63-70.
Khan AA, Dionne RA. COX‐2 inhibitors for endodontic pain. Endodontic Topics. 2002;3(1):31-40.
FitzGerald GA. COX-2 in play at the AHA and the FDA. Trends in Pharmacological Sciences. 2007;28(7):303-7.
Warner TD, Mitchell JA. COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs. The Lancet. 2008;371(9608):270-3.
Bastaki SM, Padol IT, Amir N, Hunt RH. Effect of aspirin and ibuprofen either alone or in combination on gastric mucosa and bleeding time and on serum prostaglandin E 2 and thromboxane A 2 levels in the anaesthetized rats in vivo. Molecular and Cellular Biochemistry. 2018;438:25-34.
Patrono C, Dunn MJ. The clinical significance of inhibition of renal prostaglandin synthesis. Kidney İnternational. 1987;32(1):1-12.
Perazella MA, Luciano RL. Review of select causes of drug-induced AKI. Expert Review of Clinical Pharmacology. 2015;8(4):367-71.
Khan AA, Diogenes A. Pharmacological management of acute endodontic pain. Drugs. 2021;81(14):1627-43.
Nakanishi T, Shimizu H, Hosokawa Y, Matsuo T. An immunohistological study on cyclooxygenase-2 in human dental pulp. Journal of Endodontics. 2001;27(6):385-8.
Pozzi A, Gallelli L. Pain management for dentists: the role of ibuprofen. Annali di Stomatologia. 2011;2(3-4 Suppl):3.
Attar S, Bowles WR, Baisden MK, Hodges JS, McClanahan SB. Evaluation of pretreatment analgesia and endodontic treatment for postoperative endodontic pain. Journal of Endodontics. 2008;34(6):652-5.
Nakanishi T, Matsuo T, Ebisu S. Quantitative analysis of immunoglobulins and inflammatory factors in human pulpal blood from exposed pulps. Journal of Endodontics. 1995;21(3):131-6.
Oleson M, Drum M, Reader A, Nusstein J, Beck M. Effect of preoperative ibuprofen on the success of the inferior alveolar nerve block in patients with irreversible pulpitis. Journal of Endodontics. 2010;36(3):379-82.
Noguera‐Gonzalez D, Cerda‐Cristerna B, Chavarria‐Bolaños D, Flores‐Reyes H, Pozos‐Guillen A. Efficacy of preoperative ibuprofen on the success of inferior alveolar nerve block in patients with symptomatic irreversible pulpitis: a randomized clinical trial. International Endodontic Journal. 2013;46(11):1056-62.
Tanalp J, Ersev H. Acil Endodontik Tedavide Sistemik İlaç Kullanımı. Turkiye Klinikleri Endodontics-Special Topics. 2022;8(2):55-64.
Wells LK, Drum M, Nusstein J, Reader A, Beck M. Efficacy of ibuprofen and ibuprofen/acetaminophen on postoperative pain in symptomatic patients with a pulpal diagnosis of necrosis. Journal of Endodontics. 2011;37(12):1608-12.
Flath RK, Hicks ML, Dionne RA, Pelleu Jr GB. Pain suppression after pulpectomy with preoperative flurbiprofen. Journal of Endodontics. 1987;13(7):339-47.
TİTCK. Arveles 25 mg film tablet kullanma talimatı. Available from: https://titck.gov.tr/storage/Archive/2022/kubKtAttachments/arveleskub_71ae3291-c050-42c7-b921-b8ed580a5606.pdf (Accessed 15th Feb 2025)
McCormack K, Brune K. Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs: a survey of their analgesic efficacy. Drugs. 1991;41(4):533-47.
Walker J. Interrelationships of SRS-A production and arachidonic acid metabolism in human lung tissue. Advances in Prostaglandin and Thromboxane Research. 1980;6:115-9.
Dı́az-Reval MaI, Ventura-Martı́nez R, Déciga-Campos M, Terrón JA, Cabré F, López-Muñoz FJ. Evidence for a central mechanism of action of S-(+)-ketoprofen. European Journal of Pharmacology. 2004;483(2-3):241-8.
Björkman R. Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat. Acta Anaesthesiologica Scandinavica Supplementum. 1995;103:1-44.
Ossipov M, Jerussi T, Ren K, Sun H, Porreca F. Differential effects of spinal (R)-ketoprofen and (S)-ketoprofen against signs of neuropathic pain and tonic nociception: evidence for a novel mechanism of action of (R)-ketoprofen against tactile allodynia. Pain. 2000;87(2):193-9.
Kantor TG. Ketoprofen: a review of its pharmacologic and clinical properties. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 1986;6(3):93-102.
Stoev SN, Gueоrguiev SR, Madzharov V, Lebanova H. Naproxen in pain and inflammation–a review. International Journal of Pharmaceutical and Phytopharmacological Research. 2021;11(1):142-8.
Sevelius H, Runkel R, Segre E, Bloomfield S. Bioavailability of naproxen sodium and its relationship to clinical analgesic effects. British Journal of Clinical Pharmacology. 1980;10(3):259-63.
Ong C, Lirk P, Tan C, Seymour R. An evidence-based update on nonsteroidal anti-inflammatory drugs. Clinical Medicine & Research. 2007;5(1):19-34.
Elwy AE-HM, El-Agousa I, Azzazy AE. Taurine as a Drug for Protection of Liver and Kidney against Toxicity of Dinitrotoluene on Male Rats (Applicable Study). International Journal of Pharmaceutical Research & Allied Sciences. 2019;8(1).
Glaser K. Cyclooxygenase selectivity and NSAIDs: cyclooxygenase-2 selectivity of etodolac (Lodine). Inflammopharmacology. 1995;3:335-45.
Bellamy N. Etodolac in the management of pain: a clinical review of a multipurpose analgesic. Inflammopharmacology. 1997;5:139-52.
Sirois P, Saura C, Salari H, Borgeat P. Comparative effects of etodolac, indomethacin, and benoxaprofen on icosanoid biosynthesis. Inflammation. 1984;8:353-64.
Gan TJ. Diclofenac: an update on its mechanism of action and safety profile. Current Medical Research and Opinion. 2010;26(7):1715-31.
Van Hecken A, Schwartz JI, Depré M, De Lepeleire I, Dallob A, Tanaka W, et al. Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX‐2 versus COX‐1 in healthy volunteers. The Journal of Clinical Pharmacology. 2000;40(10):1109-20.
Tegeder I, Lötsch J, Krebs S, Muth‐Selbach U, Brune K, Geisslinger G. Comparison of inhibitory effects of meloxicam and diclofenac on human thromboxane biosynthesis after single doses and at steady state. Clinical Pharmacology & Therapeutics. 1999;65(5):533-44.
Wittenberg RH, Willburger RE, Kleemeyer KS, Peskar BA. In vitro release of prostaglandins and leukotrienes from synovial tissue, cartilage, and bone in degenerative joint diseases. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 1993;36(10):1444-50.
Ku EC, Lee W, Kothari HV, Kimble EF, Liauw L, Tjan J, editors. The effects of diclofenac sodium on arachidonic acid metabolism. Seminars in Arthritis and Rheumatism; 1985.
Ku EC, Lee W, Kothari HV, Scholer DW. Effect of diclofenac sodium on the arachidonic acid cascade. The American Journal of Medicine. 1986;80(4):18-23.
Giagoudakis G, Markantonis SL. Relationships between the concentrations of prostaglandins and the nonsteroidal antiinflammatory drugs indomethacin, diclofenac, and ibuprofen. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2005;25(1):18-25.
Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proceedings of the National Academy of Sciences. 1999;96(13):7563-8.
Salter M, Strijbos P, Neale S, Duffy C, Follenfant R, Garthwaite J. The nitric oxide-cyclic GMP pathway is required for nociceptive signalling at specific loci within the somatosensory pathway. Neuroscience. 1996;73(3):649-55.
Armstrong RA. Platelet prostanoid receptors. Pharmacology & Therapeutics. 1996;72(3):171-91.
Selg E, Buccellati C, Andersson M, Rovati GE, Ezinga M, Sala A, et al. Antagonism of thromboxane receptors by diclofenac and lumiracoxib. British Journal of Pharmacology. 2007;152(8):1185-95.
Todd PA, Sorkin EM. Diclofenac sodium: a reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs. 1988;35:244-85.
Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013;21:201-32.
Chandrasekharan N, Dai H, Roos KLT, Evanson NK, Tomsik J, Elton TS, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proceedings of the National Academy of Sciences. 2002;99(21):13926-31.
Kis B, Snipes JA, Busija DW. Acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties. Journal of Pharmacology and Experimental Therapeutics. 2005;315(1):1-7.
Schwab JM, Schluesener HJ, Meyermann R, Serhan CN. COX-3 the enzyme and the concept: steps towards highly specialized pathways and precision therapeutics? Prostaglandins, Leukotrienes and Essential Fatty Acids. 2003;69(5):339-43.
Graham GG, Scott KF. Mechanism of action of paracetamol. American Journal of Therapeutics. 2005;12(1):46-55.
Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. British Medical Journal. 2004;328(7437):434.
Lages B, Weiss HJ. Inhibition of human platelet function in vitro and ex vivo by acetaminophen. Thrombosis Research. 1989;53(6):603-13.
Niemi T, Backman J, Syrjälä M, Viinikka L, Rosenberg P. Platelet dysfunction after intravenous ketorolac or propacetamol. Acta Anaesthesiologica Scandinavica. 2000;44(1):69-74.
Moore RA, Derry S, Aldington D, Wiffen PJ. Single dose oral analgesics for acute postoperative pain in adults‐an overview of Cochrane reviews. Cochrane Database of Systematic Reviews. 2015(9).
Moore RA, Derry S, Aldington D, Wiffen PJ. Adverse events associated with single dose oral analgesics for acute postoperative pain in adults‐an overview of Cochrane reviews. Cochrane Database of Systematic Reviews. 2015(10).
Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, et al. Acetaminophen‐induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42(6):1364-72.
Evans M, Fored CM, Bellocco R, Fitzmaurice G, Fryzek JP, McLaughlin JK, et al. Acetaminophen, aspirin and progression of advanced chronic kidney disease. Nephrology Dialysis Transplantation. 2009;24(6):1908-18.
Merlo J, Broms K, Lindblad U, Björck-Linné A, Liedholm H, Östergren PO, et al. Association of outpatient utilisation of non-steroidal anti-inflammatory drugs and hospitalised heart failure in the entire Swedish population. European Journal of Clinical Pharmacology. 2001;57:71-5.
Latimer N, Lord J, Grant RL, O’Mahony R, Dickson J, Conaghan PG. Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis. British Medical Journal. 2009;339.
Chiou WL. Estimation of hepatic first-pass effect of acetaminophen in humans after oral administration. Journal of Pharmaceutical Sciences. 1975;64(10):1734-5.
Perucca E, Richens A. Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs. British Journal of Clinical Pharmacology. 1979;7(2):201-6.
Rawlins M, Henderson D, Hijab A. Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration. European Journal of Clinical Pharmacology. 1977;11:283-6.
